Zucara Therapeutics Doses First Patient in Phase 2a ‘ZONE’ Trial
ZONE study to evaluate the effect of ZT-01 on preventing nighttime hypoglycemia in people with Type 1 diabetes – ZT-01 has the potential to become the first therapeutic to prevent… Read More




